Literature DB >> 9021017

Comparison of phenotype between patients with Prader-Willi syndrome due to deletion 15q and uniparental disomy 15.

S B Cassidy1, M Forsythe, S Heeger, R D Nicholls, N Schork, P Benn, S Schwartz.   

Abstract

Prader-Willi syndrome (PWS) is a complex multiple anomaly syndrome that has been shown to result from deficient expression of paternal chromosome 15(q11-q13). In most cases, it is caused either by deletion of this region in the paternally inherited chromosome 15 or by maternal uniparental disomy (UPD) of chromosome 15. In order to determine whether there are phenotypic differences between patients whose PWS is caused by these two different mechanisms, 54 affected individuals (37 with deletion, 17 with UPD) were personally examined and studied using molecular techniques. The previously recognized increased maternal age in patients with UPD and increased frequency of hypopigmentation in those with deletion were confirmed. Although the frequency and severity of most other manifestations of PWS did not differ significantly between the two groups, those with UPD were less likely to have a "typical" facial appearance. In addition, this group was less likely to show some of the minor manifestations such as skin picking, skill with jigsaw puzzles, and high pain threshold. Females and those with UPD were also older, on average. Possible mechanisms by which these differences could occur and the implications of these differences for diagnosis are described.

Entities:  

Mesh:

Year:  1997        PMID: 9021017

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  45 in total

1.  Microarray analysis of gene/transcript expression in Angelman syndrome: deletion versus UPD.

Authors:  Douglas C Bittel; Nataliya Kibiryeva; Zohreh Talebizadeh; Daniel J Driscoll; Merlin G Butler
Journal:  Genomics       Date:  2005-01       Impact factor: 5.736

2.  Contributing factors of mortality in Prader-Willi syndrome.

Authors:  Jennifer Proffitt; Kathryn Osann; Barbara McManus; Virginia E Kimonis; Janalee Heinemann; Merlin G Butler; David A Stevenson; June-Anne Gold
Journal:  Am J Med Genet A       Date:  2018-12-19       Impact factor: 2.802

3.  Skin Picking in People with Prader-Willi Syndrome: Phenomenology and Management.

Authors:  L E Bull; C Oliver; K A Woodcock
Journal:  J Autism Dev Disord       Date:  2021-01

4.  Does the Genetic Cause of Prader-Willi Syndrome Explain the Highly Variable Phenotype?

Authors:  Andreea-Iulia Dobrescu; Adela Chirita-Emandi; Nicoleta Andreescu; Simona Farcas; Maria Puiu
Journal:  Maedica (Bucur)       Date:  2016-09

5.  Aberrant White Matter Microstructure in Children and Adolescents With the Subtype of Prader-Willi Syndrome at High Risk for Psychosis.

Authors:  Akvile Lukoshe; Gerbrich E van den Bosch; Aad van der Lugt; Steven A Kushner; Anita C Hokken-Koelega; Tonya White
Journal:  Schizophr Bull       Date:  2017-09-01       Impact factor: 9.306

6.  Prader-Willi Syndrome: Clinical and Genetic Findings.

Authors:  Merlin G Butler; Travis Thompson
Journal:  Endocrinologist       Date:  2000-07

7.  Genetic subtype differences in neural circuitry of food motivation in Prader-Willi syndrome.

Authors:  L M Holsen; J R Zarcone; R Chambers; M G Butler; D C Bittel; W M Brooks; T I Thompson; C R Savage
Journal:  Int J Obes (Lond)       Date:  2008-12-02       Impact factor: 5.095

8.  Clinical management of behavioral characteristics of Prader-Willi syndrome.

Authors:  Alan Y Ho; Anastasia Dimitropoulos
Journal:  Neuropsychiatr Dis Treat       Date:  2010-05-06       Impact factor: 2.570

9.  Prader-Willi syndrome.

Authors:  Suzanne B Cassidy; Daniel J Driscoll
Journal:  Eur J Hum Genet       Date:  2008-09-10       Impact factor: 4.246

10.  Clinical and genetic analysis for four Chinese families with Prader-Willi syndrome.

Authors:  Yu-wen Zhang; Hui-ying Jia; Jie Hong; Yan Ge; Hui-jie Zhang; Chun-fang Shen; Lei Ye; Bin Cui; Xiao-ying Li; Wei-qiong Gu; Yi-fei Zhang; Wei-qing Wang; Guang Ning
Journal:  Endocrine       Date:  2009-05-07       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.